Exploring the Significance of TP53, ABCB1 and GST Polymorphisms on Susceptibility and Pharmacogenetics in Argentinian Patients with Chronic Myeloid Leukemia

被引：0

作者：

Weich, Natalia ^{[1
]}

Ferri, Cristian ^{[1
]}

Beatriz Moiraghi, Elena ^{[2
]}

Nelida Bengio, Raquel Maria ^{[3
]}

Amanda Giere, Isabel ^{[4
]}

Pavlovsky, Carolina ^{[4
]}

Larripa, Irene ^{[5
]}

Freya Fundia, Ariela ^{[1
]}

机构：

[1] CONICET Acad Nacl Med, IMEX, Lab Hematol Genet, Buenos Aires, DF, Argentina

[2] HOSP RAMOS MEJIA, Buenos Aires, DF, Argentina

[3] IIHEMA Acad Nacl Med, Buenos Aires, DF, Argentina

[4] FUNDALEU, Buenos Aires, DF, Argentina

[5] Conicet Acad Nacl Med, IMEX, Lab Hematol Genet, Caba, Argentina

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] ABCB1 and GST polymorphisms associated with TP53 status in breast cancer
Nordgard, Silje H.
Ritchie, Marylyn D.
Jensrud, Sigrid D.
Motsinger, Alison A.
Alnaes, Grethe I. G.
Lernmon, Gordon
Berg, Marianne
Gelsler, Stephanie
Moore, Jason H.
Lonning, Per Eysteln
Borresen-Dale, Anne-Lise
Kristensen, Vessela N.
PHARMACOGENETICS AND GENOMICS, 2007, 17 (02): : 127 - 136
[2] MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia
Lardo, Mabel
Castro, Marcelo
Moiraghi, Beatriz
Rojas, Francisca
Borda, Natalia
Rey, Jorge A.
Lazarowski, Alberto
BLOOD RESEARCH, 2015, 50 (03) : 154 - 159
[3] Prognostic Significance Of TP53 mutations and Single Nucleotide Polymorphisms In Acute Myeloid Leukemia
Zeichner, Simon B.
Alghamdi, Sarah
Elhammady, Gina
Poppiti, Robert
Castellano-Sanchez, Amilcar
BLOOD, 2013, 122 (21)
[4] TP53 codon 72 polymorphism in patients with chronic myeloid leukemia
Bergamaschi, G
Merante, S
Orlandi, E
Galli, A
Bernasconi, P
Cazzola, M
HAEMATOLOGICA, 2004, 89 (07) : 868 - 869
[5] Association between TP53 polymorphisms and chronic lymphocytic leukemia
Zhang, W-J
Guo, S-L
Yin, G.
Wang, G-S
Wang, Z-R
Dong, J.
Li, Q-R
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (23) : 12073 - 12079
[6] TP53 codon 72 polymorphism predicts chronic myeloid leukemia susceptibility and treatment outcome
Weich, Natalia
Ferri, Cristian
Moiraghi, Beatriz
Bengio, Raquel
Giere, Isabel
Pavlovsky, Carolina
Larripa, Irene
Fundia, Ariela
BLOOD CELLS MOLECULES AND DISEASES, 2016, 59 : 129 - 133
[7] Prognostic Significance of TP53 Mutation Class in Acute Myeloid Leukemia
Nichols, Meredith
Jambhekar, Ashwini
Bell, Timothy
Nakashima, Megan
Lovitch, Scott
LABORATORY INVESTIGATION, 2024, 104 (03) : S1460 - S1461
[8] The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia
Galimberti, Sara
Bucelli, Cristina
Arrigoni, Elena
Barate, Claudia
Grassi, Susanna
Ricci, Federica
Guerrini, Francesca
Ciabatti, Elena
Fava, Carmen
D'Avolio, Antonio
Fontanelli, Giulia
Cambrin, Giovanna Rege
Isidori, Alessandro
Loscocco, Federica
Caocci, Giovanni
Greco, Marianna
Bocchia, Monica
Aprile, Lara
Gozzini, Antonella
Scappini, Barbara
Cattaneo, Daniele
Scortechini, Anna Rita
La Nasa, Giorgio
Bosi, Alberto
Leoni, Pietro
Danesi, Romano
Saglio, Giuseppe
Visani, Giuseppe
Cortelezzi, Agostino
Petrini, Mario
Lurlo, Alessandra
Di Paolo, Antonello
ONCOTARGET, 2017, 8 (50) : 88021 - 88033
[9] Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
Boyer, Thomas
Gonzales, Fanny
Barthelemy, Adeline
Marceau-Renaut, Alice
Peyrouze, Pauline
Guihard, Soizic
Lepelley, Pascale
Plesa, Adriana
Nibourel, Olivier
Delattre, Carole
Wetterwald, Marc
Pottier, Nicolas
Plantier, Isabelle
de Botton, Stephane
Dombret, Herve
Berthon, Celine
Preudhomme, Claude
Roumier, Christophe
Cheok, Meyling
CANCERS, 2019, 11 (09)
[10] Recruiting TP53 to target chronic myeloid leukemia stem cells
Grant, Steven
HAEMATOLOGICA, 2020, 105 (05) : 1172 - 1174

← 1 2 3 4 5 →